Hera Biotech, Inc. — Form D
Hera Biotech, Inc. of SAN ANTONIO, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-23. The offering totals $5.0M, of which $796K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-09-23
- Form: D
- Accession: 0001831293-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $796K
- Remaining: $4.2M
- Investors: 8
- Date of first sale: 2025-04-11
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-558408
Issuer
- Name: Hera Biotech, Inc.
- CIK: 0001831293
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4725 COLLEGE PARK, SUITE 200, SAN ANTONIO, TX, 78249
- Phone: 2106831069
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Somer Baburek | Director | San Antonio, TX |
| Paul Castella | Director | San Antonio, TX |
| Wendy Smith | Director | San Antonio, TX |
| Neal Walsdorf, Jr. | Director | San Antonio, TX |
| Somer Baburek | Executive Officer | San Antonio, TX |
| Paul Castella | Executive Officer | San Antonio, TX |
Other filings by this issuer (5)
More